Stocks to Buy Monday : VIVK, PWER, POZN, PLBI, BUGS
VIVK - Vivakor, Inc. (VIVK) announced new markets for its VivaThermic technologies and further increased revenue projections for its VivaThermic division.
PWER - Nice publicity was able to pump it up. dump may be coming soon.

POZN - U.S. FDA approved the pharmaceutical company’s arthritis treatment Vimovo. With the approval, the Chapel Hill-based company is due a $20 million milestone payment from its marketing partner on the drug, British pharmaceutical giant AstraZeneca.

PLBI - 1200% up since publicity started in Jan. Not impressive after that. Fresh publicity started this week again.

BUGS - No specific news for the company which can justify 219% gain on Friday.This week is decisive.
